We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-4.25%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.1M
AUM Growth
-$39.1M
Cap. Flow
-$42.6M
Cap. Flow %
-48.9%
Top 10 Hldgs %
44.48%
Holding
450
New
86
Increased
61
Reduced
79
Closed
202

Top Buys

1
STZ icon
Constellation Brands
STZ
+$3.18M
2
JPM icon
JPMorgan Chase
JPM
+$3.16M
3
GIS icon
General Mills
GIS
+$2.29M
4
GILD icon
Gilead Sciences
GILD
+$2.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Top Sells

1
PG icon
Procter & Gamble
PG
+$4.04M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.96M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$2.56M
4
IBB icon
iShares Biotechnology ETF
IBB
+$2.03M
5
HUM icon
Humana
HUM
+$1.77M

Sector Composition

1 Healthcare 44.7%
2 Consumer Staples 14.06%
3 Consumer Discretionary 4.38%
4 Financials 4.11%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
26
PUT
Vertex Pharmaceuticals
VRTX
$123B
$894K 1.03%
30,900
+18,600
+151% +$1.51M
SAGE
27
DELISTED
Sage Therapeutics
SAGE
$816K 0.94%
15,978
+3,200
+25% +$151K
SRPT icon
28
Sarepta Therapeutics
SRPT
$1.82B
$797K 0.92%
29,074
-19,951
-41% -$801K
CASC
29
DELISTED
Cascadian Therapeutics, Inc.
CASC
$766K 0.88%
177,829
+24,900
+16% +$161K
ISEE
30
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$761K 0.87%
32,300
+15,300
+90% +$454K
MON
31
DELISTED
Monsanto Co
MON
$737K 0.85%
7,001
-10,312
-60% -$1.06M
GWPH
32
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$721K 0.83%
81,600
+2,700
+3% +$325K
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$123B
$703K 0.81%
9,548
+2,854
+43% +$232K
BABA icon
34
Alibaba
BABA
$282B
$699K 0.8%
7,955
+3,855
+94% +$371K
UTHR icon
35
United Therapeutics
UTHR
$22.5B
$699K 0.8%
4,873
-5,693
-54% -$727K
MNK
36
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$679K 0.78%
22,200
– –
ADBE icon
37
Adobe
ADBE
$93.5B
$649K 0.75%
+6,300
New +$667K
MDLZ icon
38
Mondelez International
MDLZ
$78.8B
$609K 0.7%
+13,734
New +$592K
GIS icon
39
PUT
General Mills
GIS
$20.7B
$595K 0.68%
115,400
+46,800
+68% +$2.9M
BIG
40
DELISTED
Big Lots, Inc.
BIG
$573K 0.66%
+11,422
New +$561K
CMG icon
41
Chipotle Mexican Grill
CMG
$43.9B
$563K 0.65%
+74,600
New +$589K
NBRV
42
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$494K 0.57%
332
+100
+43% +$133K
DD
43
CALL
DELISTED
Du Pont De Nemours E I
DD
$470K 0.54%
109,900
+38,900
+55% +$2.76M
CL icon
44
Colgate-Palmolive
CL
$75.3B
$438K 0.5%
+6,700
New +$459K
NVDA icon
45
NVIDIA
NVDA
$5.02T
$427K 0.49%
+160,000
New +$334K
LRMR icon
46
Larimar Therapeutics
LRMR
$381M
$420K 0.48%
10,994
– –
ACN icon
47
Accenture
ACN
$88.5B
$406K 0.47%
+3,467
New +$412K
HUM icon
48
CALL
Humana
HUM
$46.4B
$406K 0.47%
36,200
+1,600
+5% +$305K
YHOO
49
DELISTED
Yahoo Inc
YHOO
$387K 0.44%
10,000
-20,341
-67% -$834K
SCYX icon
50
SCYNEXIS
SCYX
$44.5M
$382K 0.44%
1,499
-135
-8% -$39.5K
1
2
3 4 5

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2016 Portfolio in Review

As of Q4 2016, FT Options held 450 positions worth $87.1M, down 31% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $42.6M in Q4 2016, closing 202 positions and reducing 79 holdings. Its most notable exit was Procter & Gamble, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 40% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Constellation Brands worth $3.07M.

  • FT Options's largest Q4 2016 buy was Constellation Brands: 20,000 shares worth $3.07M.
  • FT Options added most to General Mills in Q4 2016, an estimated $2.29M increase.
  • FT Options's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $1.06M.
  • FT Options fully exited Procter & Gamble in Q4 2016, selling an estimated $4.04M.
  • FT Options's ten largest holdings make up 44% of its $87.1M portfolio in Q4 2016.
  • FT Options opened 86 new positions and closed 202 in Q4 2016.
  • FT Options's portfolio value fell 31% quarter-over-quarter to $87.1M.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.